GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GI Innovation Inc (XKRX:358570) » Definitions » Cash Flow from Discontinued Operations

GI Innovation (XKRX:358570) Cash Flow from Discontinued Operations : ₩0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is GI Innovation Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

GI Innovation's cash flow from discontinued operations for the three months ended in Sep. 2024 was ₩0 Mil. It means GI Innovation received ₩0 Mil from the sale of part of business quarterly. GI Innovation's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Sep. 2024 was ₩0 Mil.

GI Innovation Cash Flow from Discontinued Operations Historical Data

The historical data trend for GI Innovation's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GI Innovation Cash Flow from Discontinued Operations Chart

GI Innovation Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Discontinued Operations
Get a 7-Day Free Trial - - - - -

GI Innovation Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cash Flow from Discontinued Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

GI Innovation Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GI Innovation Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of GI Innovation's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

GI Innovation Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GI Innovation Inc (XKRX:358570) » Definitions » Cash Flow from Discontinued Operations
Comparable Companies
XKRX:005690 XKRX:323990 XKRX:095700 XKRX:199800 XKRX:228760 XKRX:215600 XKRX:216080 XKRX:334970 XKRX:052020 XKRX:115450 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
Songpa-daero 167, Room 1116 of A-dong, Songpa-gu, Seoul, KOR, 05855
Website
https://www.gi-innovation.com
GI Innovation Inc is a bio-venture company that researches and develops protein new drugs through well-structured translational research. The primary research and development for GI Innovation is immuno-oncology drug and allergy disease and developing a fusion protein using the GI-SMART platform.

GI Innovation Headlines

No Headlines